VIRO — ViroGates A/S Share News
0.000.00%
Last trade - 00:00- DKK69.61m
- DKK55.91m
- DKK5.31m
Brief: ViroGates Announces New Clinical Routine Customer In Greece
Brief: Virogates Announces New Clinical Routine Customer In Spain
Brief: Virogates Starts Study To Validate suPARnostic For Guiding Early Anakinra Treatment Of COVID-19 Patients
Brief: ViroGates Announces Delay In Development And Launch Of suPARnostic POC+ Product
Brief: ViroGates: Mikkeli Central Hospital Becomes First Clinical Routine Customer In Finland
Brief: ViroGates Gets Order In Finland
Brief: Virogates Announces New Clinical Routine Customer In Spain
Brief: ViroGates Q3 Net Loss Widens To DKK 4.0 Mln
Brief: ViroGates And QIAGEN Announce Partnership
Brief: Virogates Q2 Operating Loss Narrows To DKK 4.6 Mln
Brief: ViroGates Names Mark Christian Hvidberg Da Silva New CFO
Brief: Virogates Q1 Net Loss Widens To DKK 3.7 Million
Brief: Virogates Announces Third Clinical Routine Customer
Brief: Virogates Q4 Revenue Grew By 107% YoY
Brief: ViroGates Announces Its First International Clinical Customer
Brief: Virogates Q2 Operating Loss At DKK 9.3 mln